Literature DB >> 3691580

Oxiracetam pharmacokinetics following single and multiple dose administration in the elderly.

E Perucca1, J Parini, A Albrici, M Visconti, E Ferrero.   

Abstract

The kinetics of the nootropic drug oxiracetam was studied in 6 elderly female patients (age range 69-96 years) in good physical condition. After a single oral dose (800 mg), serum oxiracetam levels reached a peak (25 +/- 6 micrograms/ml) within 1-3 h and declined thereafter with a half-life of 3 to 6 h. Eighty-four percent of the administered dose was recovered in urine as unchanged drug within 24 h. During a maintenance regimen (800 b.i.d. at 8 a.m. and 2 p.m.) for 7 days oxiracetam did not show any accumulation in serum, trough serum levels before the morning and afternoon doses being 4.6 +/- 2.3 and 17.0 +/- 8.2 micrograms/ml respectively on day 4 and 5.7 +/- 3.3 and 17.9 +/- 7.7 micrograms/ml respectively on day 7. Comparison with previous pharmacokinetic data obtained in young subjects suggests that the clearance of the drug is lower in the elderly, probably as a result of the physiological decrease in renal function in old age.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691580     DOI: 10.1007/BF03189889

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  3 in total

1.  Pharmacokinetics of oxiracetam following intravenous and oral administration in healthy volunteers.

Authors:  E Perucca; A Albrici; G Gatti; R Spalluto; M Visconti; A Crema
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jul-Sep       Impact factor: 2.441

Review 2.  Drug therapy: drug disposition in old age.

Authors:  D J Greenblatt; E M Sellers; R I Shader
Journal:  N Engl J Med       Date:  1982-05-06       Impact factor: 91.245

3.  Experimental behavioral studies with oxiracetam on different types of chronic cerebral impairment.

Authors:  S Banfi; L Dorigotti
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

  3 in total
  2 in total

1.  Pharmacokinetics of oxiracetam in elderly patients after 800 mg oral doses, comparison with non-geriatric healthy subjects.

Authors:  J B Lecaillon; J P Dubois; H Coppens; T Darragon; W Theobald; G Reumond; H Beck
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

2.  Pharmacokinetics of oxiracetam in patients with renal impairment after a 800 mg single oral dose.

Authors:  J B Lecaillon; J P Dubois; H Coppens; T Darragon; G Reumond; N Pozet; J Traeger; G Lambrey
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.